CN111995624A - Process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane - Google Patents

Process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane Download PDF

Info

Publication number
CN111995624A
CN111995624A CN202011012874.0A CN202011012874A CN111995624A CN 111995624 A CN111995624 A CN 111995624A CN 202011012874 A CN202011012874 A CN 202011012874A CN 111995624 A CN111995624 A CN 111995624A
Authority
CN
China
Prior art keywords
benzyl
diazabicyclo
reaction
nonane
racemic cis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202011012874.0A
Other languages
Chinese (zh)
Inventor
朱广友
田艳英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shayang Qinjiang Chemical Co ltd
Original Assignee
Shayang Qinjiang Chemical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shayang Qinjiang Chemical Co ltd filed Critical Shayang Qinjiang Chemical Co ltd
Priority to CN202011012874.0A priority Critical patent/CN111995624A/en
Publication of CN111995624A publication Critical patent/CN111995624A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The present invention provides a process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane comprising the steps of: step S1: preparing a platinum dehydrogenation catalyst; step S2: catalyzing piperidine ring dehydrogenation reaction by using a platinum dehydrogenation catalyst; step S3: the hydrogenation reaction is catalyzed by a chiral bronsted acid catalyst. The invention provides a method for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane with high racemic body purity and high reaction yield.

Description

Process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane
Technical Field
The invention relates to the field of preparation of medical intermediates, in particular to a method for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane.
Background
Moxifloxacin is a novel fluoroquinolone drug, the chemical structure of the moxifloxacin is obviously different from other fluoroquinolone drugs, methoxy is introduced into the 8-position carbon atom of a quinolone mother nucleus, and benzyl-2, 8-diazabicyclo [4,3,0] nonane is introduced into the 7-position carbon atom of the quinolone mother nucleus, so that the gram-positive aerobic bacteria resistance of the moxifloxacin drug is enhanced, obvious phototoxicity is not generated, the solubility of moxifloxacin drug is increased, and the risk of formation of crystalluria is reduced. The presence of these substituents provides the drug with a broad spectrum of antimicrobial activity and has been used as a chemotherapeutic agent for humans and animals, and is effective in treating infections caused by a variety of bacteria.
(S, S) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane is a key intermediate for synthesizing a new generation of fluoroquinolone drugs, moxifloxacin, a nonane mother liquor for synthesizing (S, S) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane often contains a chiral by-product (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane is unstable and is not beneficial for the subsequent synthesis of moxifloxacin, so that the racemic preparation of (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane to obtain a racemic cis product, and the racemic cis product is used as a raw material to be resolved again to obtain a target product (S, s) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane. Currently, the research on (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane is less, the recovery yield and the purity of reactants are generally not high in the industrial production process for recycling (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, and the cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane racemate is prepared by adopting a method of dehydrogenation before hydrogenation in the prior art, but the catalyst dosage is larger in the second hydrogenation step, the catalytic efficiency is still not ideal, and the total yield of the reaction and the purity of the product are influenced.
Therefore, there is a need to develop a method for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane with high racemic purity and high reaction yield.
Disclosure of Invention
The invention aims to provide a method for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane with high racemic body purity and high reaction yield.
The technical purpose of the invention is realized by the following technical scheme:
a process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane comprising the steps of:
step S1: preparation of platinum dehydrogenation catalyst: loading noble metal platinum carbon on a solid carrier by dipping into a dipping solution containing noble metal ions by adopting a dipping method;
step S2: dehydrogenation reaction of piperidine ring: subjecting (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, which is subjected to optical resolution, to a piperidine ring dehydrogenation reaction with a platinum dehydrogenation catalyst;
step S3: hydrogenation reaction: and (2) carrying out hydrogenation reaction on the 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine obtained in the step (S2) and a chiral bronsted acid catalyst in the environment of a reaction solvent under certain reaction conditions to obtain the target product, namely the racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane.
As a further configuration of the present invention, the ratio of the chiral bronsted acid catalyst to the 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine in the step S3 by weight parts is: 0.005:1-0.01:1.
As a further arrangement of the invention, the chiral bronsted acid catalyst is a thiourea derivative catalyst.
As a further configuration of the present invention, the ratio of the weight of the platinum dehydrogenation catalyst of step S2 to the weight of (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane is 0.1:1 to 2: 1.
As a further configuration of the present invention, the reaction solvent in step S3 includes, by weight, 40-50 parts of tetrahydrofuran and 5-8 parts of lauryl glycol hydroxypropyl ether.
As a further configuration of the present invention, the reaction solvent in step S3 further includes 1 to 5 parts by weight of linoleyl lactate.
As a further configuration of the present invention, the loading amount of the platinum carbon on the solid support in the step S2 is 0.2% to 5% by weight of the solid support.
As a further configuration of the present invention, the solid support of step S1 is one of silica, porous alumina and silica alumina gel.
As a further configuration of the invention, the reaction temperature in the piperidine ring dehydrogenation reaction of the step S3 is 130-140 ℃, and the reaction time is 3-5 h.
As a further configuration of the present invention, the reaction conditions in the hydrogenation reaction of step S3 are: after nitrogen is used for oxygen removal, hydrogen is introduced for reaction, the reaction temperature is 60-80 ℃, and the reaction time is 3-5 h.
The invention has the beneficial effects that:
1. the hydrogenation reaction of the pyridine ring adopts a thiourea derivative chiral bronsted acid catalyst, the thiourea derivative catalyst can realize ultrahigh-efficiency catalysis only depending on weak intermolecular forces such as hydrogen bonds, van der waals force and the like, the high-efficiency catalysis can be realized only by using a small amount in the hydrogenation reaction, the chiral selectivity of the thiourea derivative catalyst is high, and the catalytic hydrogenation is carried out on (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, so that the selectivity of the reaction is effectively improved, and the yield and the product purity of the reaction are improved.
2. According to the invention, in the hydrogenation reaction solvent, the lauryl glycol hydroxypropyl ether can improve the contact area of the thiourea derivative catalyst and two phases of the reactant, improve the reaction degree of the catalytic reaction of the catalyst at the interface, and improve the yield and the product purity of the reaction.
3. The ester group and the hydroxyl optical energy group of the linolenol lactate in the hydrogenation reaction solvent can improve the hydrogen bond acting force in the reaction system, thereby improving the catalytic activity of the thiourea derivative catalyst, effectively improving the hydrogenation reaction degree, and further improving the reaction yield and the product purity.
Detailed Description
The technical solution of the present invention will be clearly and completely described below with reference to specific embodiments. It is to be understood that the described embodiments are merely a few embodiments of the invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments of the present invention without any inventive step, are within the scope of the present invention.
First, an embodiment
Example 1
A process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane comprising the steps of:
step S1: preparation of platinum dehydrogenation catalyst: loading noble metal platinum carbon on solid carrier silicon dioxide by dipping into dipping solution containing noble metal ions by adopting a dipping method, wherein the loading amount of the platinum carbon on the solid carrier is 0.2 percent of the weight of the solid carrier;
step S2: dehydrogenation reaction of piperidine ring: carrying out piperidine ring dehydrogenation reaction on (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane subjected to optical resolution and a platinum dehydrogenation catalyst at the reaction temperature of 130 ℃ in a weight part ratio of 1:0.1 for 3 h;
step S3: hydrogenation reaction: mixing a chiral bronsted acid catalyst with the 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine obtained in the step S2 in parts by weight: 0.005:1, and carrying out hydrogenation reaction for 3h in the environment of reaction solvents of 40 parts of tetrahydrofuran, 5 parts of lauryl glycol hydroxypropyl ether and 1 part of linoleol lactate and in the environment of nitrogen gas introduction at the reaction temperature of 60 ℃ to obtain the target product racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, wherein the yield is 86.5 percent and the purity of the product is 99.1 percent.
Example 2
A process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane comprising the steps of:
step S1: preparation of platinum dehydrogenation catalyst: loading noble metal platinum carbon on the solid carrier porous alumina by dipping into a dipping solution containing noble metal ions by adopting a dipping method, wherein the loading amount of the platinum carbon on the solid carrier is 5 percent of the weight of the solid carrier;
step S2: dehydrogenation reaction of piperidine ring: carrying out piperidine ring dehydrogenation reaction on (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane subjected to optical resolution and a platinum dehydrogenation catalyst at the reaction temperature of 140 ℃ for 5h, wherein the weight part of the catalyst is 1: 2;
step S3: hydrogenation reaction: mixing a chiral bronsted acid catalyst with the 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine obtained in the step S2 in parts by weight: 0.01:1, and carrying out hydrogenation reaction for 5h in the environment of reaction solvents of 50 parts of tetrahydrofuran, 8 parts of lauryl glycol hydroxypropyl ether and 5 parts of linoleol lactate and in the environment of nitrogen gas introduction at the reaction temperature of 80 ℃ to obtain the target product racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, wherein the yield is 89.4 percent and the purity of the product is 99.6 percent.
Example 3
A process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane comprising the steps of:
step S1: preparation of platinum dehydrogenation catalyst: loading noble metal platinum carbon on a solid carrier silica-alumina gel by dipping into a dipping solution containing noble metal ions by adopting a dipping method, wherein the loading amount of the platinum carbon on the solid carrier is 2 percent of the weight of the solid carrier;
step S2: dehydrogenation reaction of piperidine ring: carrying out piperidine ring dehydrogenation reaction on (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane subjected to optical resolution and a platinum dehydrogenation catalyst at the reaction temperature of 135 ℃ for 4h in a weight part ratio of 1: 1;
step S3: hydrogenation reaction: mixing a chiral bronsted acid catalyst with the 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine obtained in the step S2 in parts by weight: 0.008:1, carrying out hydrogenation reaction for 4h in the environment of reaction solvents of 45 parts of tetrahydrofuran, 6 parts of lauryl glycol hydroxypropyl ether and 3 parts of linoleol lactate and in the environment of nitrogen gas introduction at the reaction temperature of 70 ℃ to obtain the target product racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, wherein the yield is 87.2 percent and the purity of the product is 99.3 percent.
Example 4
A process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane comprising the steps of:
step S1: preparation of platinum dehydrogenation catalyst: loading noble metal platinum carbon on solid carrier silicon dioxide by dipping into a dipping solution containing noble metal ions by adopting a dipping method, wherein the loading amount of the platinum carbon on the solid carrier is 2 percent of the weight of the solid carrier;
step S2: dehydrogenation reaction of piperidine ring: carrying out piperidine ring dehydrogenation reaction on (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane subjected to optical resolution and a platinum dehydrogenation catalyst at the reaction temperature of 135 ℃ for 4h in a weight part ratio of 1: 1;
step S3: hydrogenation reaction: mixing a chiral bronsted acid catalyst with the 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine obtained in the step S2 in parts by weight: 0.008:1, carrying out hydrogenation reaction for 4h in the environment of reaction solvents of 45 parts of tetrahydrofuran and 3 parts of linoleol lactate and in the environment of nitrogen gas introduction at the reaction temperature of 70 ℃, and obtaining the target product racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, wherein the yield is 78.4 percent and the purity of the product is 90.1 percent.
Example 5
A process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane comprising the steps of:
step S1: preparation of platinum dehydrogenation catalyst: loading noble metal platinum carbon on solid carrier silicon dioxide by dipping into a dipping solution containing noble metal ions by adopting a dipping method, wherein the loading amount of the platinum carbon on the solid carrier is 2 percent of the weight of the solid carrier;
step S2: dehydrogenation reaction of piperidine ring: carrying out piperidine ring dehydrogenation reaction on (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane subjected to optical resolution and a platinum dehydrogenation catalyst at the reaction temperature of 135 ℃ for 4h in a weight part ratio of 1: 1;
step S3: hydrogenation reaction: mixing a chiral bronsted acid catalyst with the 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine obtained in the step S2 in parts by weight: 0.008:1, carrying out hydrogenation reaction for 4h in the environment of reaction solvents of 45 parts of tetrahydrofuran and 6 parts of lauryl glycol hydroxypropyl ether at the temperature of 70 ℃ in the environment of nitrogen gas introduction to obtain the target product racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, wherein the yield is 76.8 percent and the purity of the product is 91.6 percent.
Example 6
A process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane comprising the steps of:
step S1: preparation of platinum dehydrogenation catalyst: loading noble metal platinum carbon on solid carrier silicon dioxide by dipping into a dipping solution containing noble metal ions by adopting a dipping method, wherein the loading amount of the platinum carbon on the solid carrier is 2 percent of the weight of the solid carrier;
step S2: dehydrogenation reaction of piperidine ring: carrying out piperidine ring dehydrogenation reaction on (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane subjected to optical resolution and a platinum dehydrogenation catalyst at the reaction temperature of 135 ℃ for 4h in a weight part ratio of 1: 1;
step S3: hydrogenation reaction: mixing a chiral bronsted acid catalyst with the 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine obtained in the step S2 in parts by weight: 0.008:1, in the environment of 45 parts of reaction solvent tetrahydrofuran, in the environment of nitrogen gas introduction, at the reaction temperature of 70 ℃, carrying out hydrogenation reaction for 4 hours to obtain the target product racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, with the yield of 72.4% and the product purity of 87.4%.
The principles and embodiments of the present invention are explained herein using specific examples, which are set forth only to help understand the method and its core ideas of the present invention. It should be noted that, for those skilled in the art, it is possible to make various improvements and modifications to the present invention without departing from the principle of the present invention, and those improvements and modifications also fall within the scope of the claims of the present invention.

Claims (10)

1. A process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, which comprises the steps of:
step S1: preparation of platinum dehydrogenation catalyst: loading noble metal platinum carbon on a solid carrier by dipping into a dipping solution containing noble metal ions by adopting a dipping method;
step S2: dehydrogenation reaction of piperidine ring: subjecting (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane, which is subjected to optical resolution, to a piperidine ring dehydrogenation reaction with a platinum dehydrogenation catalyst;
step S3: hydrogenation reaction: and (2) carrying out hydrogenation reaction on the 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine obtained in the step (S2) and a chiral bronsted acid catalyst in the environment of a reaction solvent under certain reaction conditions to obtain the target product, namely the racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane.
2. The process for preparing racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane according to claim 1, wherein the ratio of parts by weight of the chiral bronsted acid catalyst to the weight of 6-benzyl-1, 2,3, 4-tetrahydro-pyrrolo [3, 4-b ] pyridine in step S3 is: 0.005:1-0.01:1.
3. A process for the preparation of racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane according to claim 1, characterised in that the chiral bronsted acid catalyst is a thiourea derivative catalyst.
4. The process for preparing racemic cis 8-benzyl-2, 8-diazabicyclo [4,3,0] nonane according to claim 1, wherein the ratio of the weight of the platinum dehydrogenation catalyst to the weight of (R, R) -8-benzyl-2, 8-diazabicyclo [4,3,0] nonane in parts by weight of step S2 is from 0.1:1 to 2: 1.
5. The process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane according to claim 1, wherein the reaction solvent in step S3 comprises 40 to 50 parts by weight of tetrahydrofuran and 5 to 8 parts by weight of lauryl glycol hydroxypropyl ether.
6. The process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane according to claim 5, wherein the reaction solvent in step S3 further comprises 1 to 5 parts by weight of linoleyl lactate.
7. The process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane according to claim 1, wherein the loading of the platinum carbon in step S2 is from 0.2% to 5% by weight of the solid support, based on the weight percentage.
8. The process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane according to claim 1, wherein the solid support of step S1 is one of silica, porous alumina and silica alumina gel.
9. The process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane according to claim 1, wherein the reaction temperature in the step S3 piperidine ring dehydrogenation reaction is 130 ℃ to 140 ℃ and the reaction time is 3 to 5 hours.
10. The process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane according to claim 1, wherein the reaction conditions in the hydrogenation reaction of step S3 are: after nitrogen is used for oxygen removal, hydrogen is introduced for reaction, the reaction temperature is 60-80 ℃, and the reaction time is 3-5 h.
CN202011012874.0A 2020-09-24 2020-09-24 Process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane Pending CN111995624A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011012874.0A CN111995624A (en) 2020-09-24 2020-09-24 Process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011012874.0A CN111995624A (en) 2020-09-24 2020-09-24 Process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane

Publications (1)

Publication Number Publication Date
CN111995624A true CN111995624A (en) 2020-11-27

Family

ID=73474806

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011012874.0A Pending CN111995624A (en) 2020-09-24 2020-09-24 Process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane

Country Status (1)

Country Link
CN (1) CN111995624A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574197A (en) * 2020-12-07 2021-03-30 泰安汉威集团有限公司 Chiral purification method of compound C

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429199A (en) * 2008-09-08 2009-05-13 华东师范大学 Process for producing racemic cis-8-benzyl-7, 9-dioxo-2, 8-diazabicyclo [4.3.0] nonyl hydride
CN103254121A (en) * 2013-04-08 2013-08-21 洛阳师范学院 Synthesis method of (3R, 4R)-N-PG-4-methyl-3-methylaminopiperidine
CN103788090A (en) * 2014-01-26 2014-05-14 绍兴文理学院 Racemization method of (1R, 6S)-8-benzyl-7, 9-dioxo-2, 8- diazabicyclo (4, 3, 0) nonane
CN105153155A (en) * 2015-09-18 2015-12-16 华东师范大学 Preparation method for 6-benzyl-5,7-dioxo-1,2,3,4-tetrahydro-pyrrolo-[3,4-b] pyridine
CN108690017A (en) * 2018-05-04 2018-10-23 新乡学院 A kind of preparation method of the moxifloxacin side chain intermediate of rhodium catalysis

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101429199A (en) * 2008-09-08 2009-05-13 华东师范大学 Process for producing racemic cis-8-benzyl-7, 9-dioxo-2, 8-diazabicyclo [4.3.0] nonyl hydride
CN103254121A (en) * 2013-04-08 2013-08-21 洛阳师范学院 Synthesis method of (3R, 4R)-N-PG-4-methyl-3-methylaminopiperidine
CN103788090A (en) * 2014-01-26 2014-05-14 绍兴文理学院 Racemization method of (1R, 6S)-8-benzyl-7, 9-dioxo-2, 8- diazabicyclo (4, 3, 0) nonane
CN105153155A (en) * 2015-09-18 2015-12-16 华东师范大学 Preparation method for 6-benzyl-5,7-dioxo-1,2,3,4-tetrahydro-pyrrolo-[3,4-b] pyridine
CN108690017A (en) * 2018-05-04 2018-10-23 新乡学院 A kind of preparation method of the moxifloxacin side chain intermediate of rhodium catalysis

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112574197A (en) * 2020-12-07 2021-03-30 泰安汉威集团有限公司 Chiral purification method of compound C
CN112574197B (en) * 2020-12-07 2021-12-31 泰安汉威集团有限公司 Chiral purification method of compound C

Similar Documents

Publication Publication Date Title
EP2771006B1 (en) Process for making beta 3 angonists and intermediates
CN114524701B (en) N-axis chiral pyrrole derivative and synthesis method thereof
CN111253406B (en) Preparation method of medical intermediate dihydrobenzo [4, 5] imidazo [1, 2-a ] pyrimidine derivative
CN111995624A (en) Process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane
CN111087395A (en) Preparation method for synthesizing pyrroloquinoline quinone by four-step method
CN111004198B (en) Synthetic method of benzopyran derivative
CN112110916B (en) Process for preparing racemic cis-8-benzyl-2, 8-diazabicyclo [4,3,0] nonane
CN109400600A (en) The novel preparation method of 10 α-methoxyl group -9,10- dihydro lysergol
CN115322065A (en) Method for industrially producing deuterated pharmaceutical intermediate by adopting combination of immobilized nickel and organic base for catalysis
JP5925381B2 (en) Compound [4- (2-amino-10-methyl-4-oxo-6,7,8,9-tetrahydro-4a, 7-epiminopyrimido [4,5-b] [1,4] diazepine-5 (4H) -Yl) benzoyl] -glutamate and its production
CN109384643B (en) Method for preparing sorbitol
RU2291862C2 (en) Method for preparing aryl-condensed polycyclic lactams
CN111171022B (en) Synthesis method of 1-hydroxy-pyrrolo [2,3-c ] piperidine
KR102292794B1 (en) Preparation method of 2-substituted 1,2,3,4-tetrahydroquinoline compound
CN116162055B (en) Method for preparing piperidine derivative from pyridine N-oxide derivative
CN112979588B (en) Preparation of 2, 5-furandimethanol by transfer hydrogenation
CN114345382B (en) Biochar covalent immobilized phosphoric acid catalyst and preparation method and application thereof
CN114436803B (en) Preparation method of 3- (4-chlorophenyl) -1, 5-diphenylpentane-1, 5-dione compound
CN109810042B (en) Preparation method of asymmetric bis (indolyl) methane and derivative thereof
CN112979643B (en) 3- (2-chloroethyl) -9-hydroxy-2-methyl-4H-pyrido [1,2-a ] pyrimidin-4-one
CN117417295A (en) Synthesis method of 5-methylnicotinic acid
CN116410146A (en) One-step process for converting polyols to nitrogen-containing heterocycles using heterogeneous metal catalysts
RU2203885C2 (en) Method of synthesis of para-aminobenzoic acid ethyl ester
CN118063455A (en) Method for preparing Ruimei pam intermediate
CN116813612A (en) Method for preparing ramiazepam intermediate by chemical-enzymatic method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20201127

RJ01 Rejection of invention patent application after publication